Literature DB >> 8756327

Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase.

N C Strynadka1, R Martin, S E Jensen, M Gold, J B Jones.   

Abstract

The structure of the plasmid-mediated beta-lactamase TEM-1 has been solved in complex with a designed boronic acid inhibitor (1R)-1-acetamido-2-(3-carboxyphenyl)ethane boronic acid at 1.7 A resolution. The boronate inhibitor was designed based on the crystallographic coordinates of the acyl-enzyme intermediate of TEM-1 bound to the substrate penicillin G. The boronate-TEM-1 complex is highly ordered and defines a novel transition state analogue of the deacylation step in the beta-lactamase reaction pathway. The design principles of this highly effective inhibitor (Ki = 110 nM) and the resulting structural and mechanistic implications are presented.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756327     DOI: 10.1038/nsb0896-688

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  33 in total

1.  The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.

Authors:  R A Powers; J Blázquez; G S Weston; M I Morosini; F Baquero; B K Shoichet
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Dynamical aspects of TEM-1 beta-lactamase probed by molecular dynamics.

Authors:  Danilo Roccatano; Gianluca Sbardella; Massimiliano Aschi; Gianfranco Amicosante; Cecilia Bossa; Alfredo Di Nola; Fernando Mazza
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

3.  Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.

Authors:  Wei Ke; Jared M Sampson; Claudia Ori; Fabio Prati; Sarah M Drawz; Christopher R Bethel; Robert A Bonomo; Focco van den Akker
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

4.  Negative Epistasis and Evolvability in TEM-1 β-Lactamase--The Thin Line between an Enzyme's Conformational Freedom and Disorder.

Authors:  Eynat Dellus-Gur; Mikael Elias; Emilia Caselli; Fabio Prati; Merijn L M Salverda; J Arjan G M de Visser; James S Fraser; Dan S Tawfik
Journal:  J Mol Biol       Date:  2015-05-22       Impact factor: 5.469

Review 5.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

6.  Exploring the potential impact of an expanded genetic code on protein function.

Authors:  Han Xiao; Fariborz Nasertorabi; Sei-Hyun Choi; Gye Won Han; Sean A Reed; Raymond C Stevens; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

7.  Influence of substrates and inhibitors on the structure of Klebsiella pneumoniae carbapenemase-2.

Authors:  Ben A Shurina; Richard C Page
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-04

8.  Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.

Authors:  Meha P Patel; Liya Hu; Cameron A Brown; Zhizeng Sun; Carolyn J Adamski; Vlatko Stojanoski; Banumathi Sankaran; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

9.  Fragment-guided design of subnanomolar β-lactamase inhibitors active in vivo.

Authors:  Oliv Eidam; Chiara Romagnoli; Guillaume Dalmasso; Sarah Barelier; Emilia Caselli; Richard Bonnet; Brian K Shoichet; Fabio Prati
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-05       Impact factor: 11.205

10.  EstB from Burkholderia gladioli: a novel esterase with a beta-lactamase fold reveals steric factors to discriminate between esterolytic and beta-lactam cleaving activity.

Authors:  Ulrike G Wagner; Evamaria I Petersen; Helmut Schwab; Christoph Kratky
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.